https://cambridgebrc.nihr.ac.uk/wp-content/uploads/2021/11/WEB-Youngwomansufferingfromabdominalpain.jpg
400
600
cbrcprod
https://cambridgebrc.nihr.ac.uk/wp-content/uploads/2024/04/Cambridge_BRC_NIHR_logo.png
cbrcprod2024-02-22 13:09:032025-01-10 17:55:45Treating newly-diagnosed Crohn’s patients with advanced therapy leads to dramatic improvements in outcomesThe NIHR Cambridge BRC is part of the NIHR and hosted by Cambridge University Hospitals NHS Foundation Trust in partnership with the University of Cambridge. We are at the heart of the Cambridge Biomedical Campus, Europe’s largest health research area.
Contact Us
Cambridge Biomedical Research Centre
Box 277
Hills Road
Cambridge
CB2 0QQ
Tel: 01223 348490
Are you a health researcher in East England? Have you used PPI to benefit your research? Tell us about it here (deadline 26 May) & you could be selected to present your research in a poster or short talk at the East of England PPI Showcase, 16 Jun #NIHR20
⏰ Three days left to apply to present at the Cambridge NMAP Research Conference by midnight this Sunday!
➡️ https://forms.office.com/pages/responsepage.aspx?id=slTDN7CF9UeyIge0jXdO4-ud-Jzaz9hDmjThrNePfQtUMjkxRzFZNTJQV01NMkVXWU5LTUE0SldSSi4u&route=shorturl
Share your work, meet & learn from colleagues across the region.
⚠️ Only a few free tickets left so register soon here:
👉 https://www.eventbrite.com/e/cambridge-nursing-midwifery-and-allied-professions-research-conference-tickets-1979969052736?aff=oddtdtcreator

Professor of Translational Immunology, Consultant Nephrologist, Director of Clinical Studies.














Antibiotic resistance determination using Enterococcus faecium whole-genome sequences: a diagnostic accuracy study using genotypic and phenotypic data
A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn’s disease (PROFILE): a multicentre, open-label randomised controlled trial
Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study
Hospitalisation for COVID-19 predicts long lasting cerebrovascular impairment: A prospective observational cohort study